News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
777,775 Results
Type
Article (54506)
Company Profile (370)
Press Release (722881)
Multimedia
Podcasts (139)
Webinars (24)
Section
Business (214366)
Career Advice (2262)
Deals (37375)
Drug Delivery (156)
Drug Development (85989)
Employer Resources (179)
FDA (17443)
Job Trends (15847)
News (364250)
Policy (34806)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (3)
2027 Genetown Standard (4)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (6)
Academia (2903)
Academic (1)
Accelerated approval (56)
Adcomms (36)
Allergies (187)
Alliances (53046)
ALS (230)
Alzheimer's disease (1909)
Antibody-drug conjugate (ADC) (536)
Approvals (17817)
Artificial intelligence (743)
Autoimmune disease (339)
Automation (61)
Bankruptcy (385)
Best Places to Work (12083)
BIOSECURE Act (22)
Biosimilars (235)
Biotechnology (247)
Bladder cancer (205)
Brain cancer (81)
Breast cancer (817)
Cancer (6402)
Cardiovascular disease (509)
Career advice (1926)
Career pathing (48)
CAR-T (375)
CDC (71)
Celiac Disease (3)
Cell therapy (1037)
Cervical cancer (53)
Clinical research (74298)
Collaboration (2269)
Company closure (6)
Compensation (1464)
Complete response letters (94)
COVID-19 (2958)
CRISPR (122)
C-suite (1230)
Cystic fibrosis (160)
Data (8470)
Decentralized trials (3)
Denatured (38)
Depression (179)
Dermatology (95)
Diabetes (633)
Diagnostics (7342)
Digital health (61)
Diversity (12)
Diversity, equity & inclusion (47)
Drug discovery (361)
Drug pricing (219)
Drug shortages (33)
Duchenne muscular dystrophy (308)
Earnings (94116)
Editorial (73)
Employer branding (21)
Employer resources (158)
Events (125780)
Executive appointments (1150)
FDA (21374)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (18)
Frontotemporal dementia (36)
Funding (1863)
Gene editing (261)
Generative AI (66)
Gene therapy (816)
GLP-1 (1167)
Government (5081)
Grass and pollen (8)
Guidances (417)
Healthcare (20153)
HIV (87)
Huntington's disease (60)
IgA nephropathy (108)
Immunology and inflammation (330)
Immuno-oncology (112)
Indications (201)
Infectious disease (3332)
Inflammatory bowel disease (232)
Inflation Reduction Act (15)
Influenza (143)
Intellectual property (307)
Interviews (381)
IPO (17257)
IRA (51)
Job creations (4074)
Job search strategy (1584)
JPM (66)
Kidney cancer (22)
Labor market (108)
Layoffs (635)
Leadership (46)
Legal (8481)
Liver cancer (110)
Longevity (35)
Lung cancer (864)
Lymphoma (457)
Machine learning (64)
Management (61)
Manufacturing (1146)
MASH (209)
Medical device (14572)
Medtech (14715)
Mergers & acquisitions (21380)
Metabolic disorders (1645)
mRNA (253)
Multiple sclerosis (199)
NASH (24)
Neurodegenerative disease (470)
Neuropsychiatric disorders (114)
Neuroscience (3566)
Neurotech (1)
NextGen: Class of 2026 (7059)
Non-profit (4812)
Now hiring (79)
Obesity (772)
Opinion (326)
Ovarian cancer (241)
Pain (269)
Pancreatic cancer (336)
Parkinson's disease (397)
Partnered (35)
Patents (629)
Patient recruitment (724)
Peanut (67)
People (62624)
Pharmaceutical (70)
Pharmacy benefit managers (33)
Phase 1 (23310)
Phase 2 (32672)
Phase 3 (24311)
Pipeline (9459)
Policy (347)
Postmarket research (2711)
Preclinical (10182)
Press Release (71)
Prostate cancer (333)
Psychedelics (65)
Radiopharmaceuticals (361)
Rare diseases (1182)
Real estate (6460)
Recruiting (72)
Regulatory (27051)
Reports (58)
Research institute (2647)
Resumes & cover letters (381)
Rett syndrome (40)
RNA editing (25)
RSV (94)
Schizophrenia (190)
Series A (319)
Series B (226)
Service/supplier (12)
Sickle cell disease (126)
Special edition (31)
Spinal muscular atrophy (176)
Sponsored (52)
Startups (4014)
State (2)
Stomach cancer (21)
Supply chain (132)
Tariffs (92)
The Weekly (98)
Vaccines (1230)
Venture capital (122)
Weight loss (512)
Women's health (134)
Worklife (23)
Date
Today (134)
Last 7 days (796)
Last 30 days (3538)
Last 365 days (31544)
2026 (14823)
2025 (31493)
2024 (36700)
2023 (41653)
2022 (52907)
2021 (57509)
2020 (56155)
2019 (49119)
2018 (37115)
2017 (34216)
2016 (33830)
2015 (39918)
2014 (33551)
2013 (29073)
2012 (31064)
2011 (31516)
2010 (29531)
Location
Africa (843)
Alabama (98)
Alaska (7)
Arizona (370)
Arkansas (15)
Asia (43836)
Australia (7504)
California (13937)
Canada (3912)
China (1497)
Colorado (592)
Connecticut (611)
Delaware (428)
Europe (97905)
Florida (2064)
Georgia (454)
Hawaii (3)
Idaho (66)
Illinois (1136)
India (96)
Indiana (625)
Iowa (24)
Japan (571)
Kansas (140)
Kentucky (53)
Louisiana (47)
Maine (89)
Maryland (1672)
Massachusetts (10119)
Michigan (374)
Minnesota (760)
Mississippi (6)
Missouri (160)
Montana (37)
Nebraska (30)
Nevada (148)
New Hampshire (90)
New Jersey (3647)
New Mexico (35)
New York (3667)
North Carolina (1787)
North Dakota (11)
Northern California (6993)
Ohio (420)
Oklahoma (26)
Oregon (43)
Pennsylvania (2777)
Puerto Rico (30)
Rhode Island (51)
South America (1246)
South Carolina (88)
South Dakota (2)
Southern California (5498)
Tennessee (220)
Texas (2231)
United States (49393)
Utah (412)
Vermont (1)
Virginia (349)
Washington D.C. (83)
Washington State (1110)
West Virginia (4)
Wisconsin (136)
Wyoming (2)
777,775 Results for "cell based delivery inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
InSphero AG Acquires PhenoVista Biosciences, Inc. to Expand Advanced 3D, Cell-based Assay Capabilities
May 20, 2026
·
3 min read
Press Releases
Sana Biotechnology Presents Preclinical Data for In Vivo CAR T Cell Therapy SG293 Surrogate Demonstrating Cell-Specific Delivery, Potent CAR T Cell Generation, and Deep B Cell Depletion in NHPs
May 13, 2026
·
8 min read
Press Releases
Vyriad Launches G-Link: A Modular Platform Advancing T-Cell Targeted Lentiviral Vector Delivery for In Vivo and Ex Vivo Applications
May 21, 2026
·
4 min read
Press Releases
Lightship Inc. Acquires Veda Trials to Expand Community-Based Clinical Research Delivery
The acquisition expands scalable trial operations across real-world care settings
February 4, 2026
·
1 min read
Press Releases
Lightship Inc. Acquires Veda Trials to Expand Community-Based Clinical Research Delivery
February 5, 2026
·
3 min read
Press Releases
High-Precision Base-Editing Therapy Demonstrates Durable VOC-Free Efficacy and Favorable Safety in Sickle Cell Disease
June 2, 2026
·
4 min read
Press Releases
Atrandi Biosciences Expands Leadership Team to Accelerate Global Adoption of Capsule-Based Single-Cell Technology
May 19, 2026
·
4 min read
Funding
NewLimit snags $435M after seeing age reversal in human liver cells
NewLimit is pressing the gas, speeding into clinical trials much sooner than expected after lab research showed its epigenetic reprogramming asset reversed aging in human liver cells.
June 3, 2026
·
2 min read
·
Gabrielle Masson
Press Releases
Bracco Launches BubbleGen™ Early Access Program for Microbubble-Based Cell Selection and Activation at ISCT
May 5, 2026
·
3 min read
Approvals
BeOne wins mantle cell lymphoma approval, opening new therapy class
Beqalzi is the first BCL2 inhibitor approved for relapsed or refractory mantle cell lymphoma.
May 14, 2026
·
2 min read
·
Tristan Manalac
1 of 77,778
Next
